Cardiac Catheterization Market: Evolving Technology, Trends and Top Industry Players Analysis – Abbott, Johnson & Johnson Private Limited, Medtronic – Forecast till 2027

According to a recent study published by the Market Research Future analysts, the global Cardiac Catheterization Market is growing at a moderate growth rate; mainly due to increasing number of people suffering from cardiac diseases leading to the requirement of surgical procedures. The factors that are responsible for driving the growth of the market are rising occurrence of cardiovascular diseases, growing number of cardiac surgeries, a high number of diabetic and obese population, huge geriatric population, and changing living standards leading to development of cardiac disorders.

Try Sample Report Here @ https://www.marketresearchfuture.com/sample_request/972 .

Cardiac catheterization is a widely used procedure in different cardiovascular surgeries. This procedure involves insertion of a small tube into a chamber or vessel of the heart. It is the most commonly used technique for the diagnosis and treatment of cardiac diseases.

Global Cardiac Catheterization Market – Major Key Players
The global market consist of players such as Boston Scientific Corporation (US), Coloplast (Denmark), Dispocard GmbH (Germany), Becton, Dickinson and Company (US), St. Jude Medical (US), Abbott (US), Johnson & Johnson Private Limited (US), Teleflex Incorporated (US)., Smiths Medical (US), Edwards Life Sciences Corporation (US), Medtronic Inc (US), Rochester Medical Corporation (U.S), Maquet Medical India Private Limited (India), Terumo Medical Corporation (Japan), and others. These are some of the prominent players at the forefront of competition in the global cardiac catheterization market.

Global Cardiac Catheterization Market - Competitive Analysis
The market for cardiac catheterization is well established market with number of companies operating in this market. There are large number of companies involved in the development of the products, including the devices, and accessories for the various types of cardiac catheters.
Abbott is one of the big company that is involved in the development of the cardiac catheterization products. The company has had some great developments in the cardiac catheterization segment in 2017.

Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/972 .

News
In November 2017, Abbott announced the approval of its MitraClip device for treatment of people with mitral regurgitation (MR) from Japan's Ministry of Health, Labour and Welfare (MHLW).
In May 2017, Abbott announced the CE Mark of the “TactiCath Contact Force Ablation Catheter, Sensor Enabled”. The product is developed to make it easier for physicians to more effectively treat atrial fibrillation (AF).
In March 2017, Abbott announced U.S. Food and Drug Administration (FDA) approval of the “FlexAbility Ablation Catheter, Sensor Enabled” designed to improve the versatility and precision during cardiac ablation procedures to treat atrial flutter, a type of irregular heartbeat.
In January 2017, Abbott announced the U.S. launch and the first commercial uses of the new “EnSite Precision cardiac mapping system” and “Advisor FL Circular Mapping Catheter, Sensor Enabled” to map cardiac arrhythmias during ablation treatments.

Global Cardiac Catheterization Market - Segments
Global Cardiac Catheterization market has been segmented on the basis of types and applications. By types which majorly include Angiographic Balloon Catheter, Arterial Embolectomy, Bipolar Pacing Shrouded Pin, Hexapolar Balloon Pacing, Optical Fiber Scope, Semi Flotating Electrode and Others. Whereas by applications includes Coronary angiogram, Right heart catheterization, Heart biopsy, Balloon angioplasty, Valve replacement and others.

Global Cardiac Catheterization Market - Regional Analysis
Owing to the presence of huge patients suffering from cardiovascular diseases, America dominates the global cardiac catheterization market. According to the Centers for Disease Control and Prevention, 28.4 million adults were suffering from heart diseases by January 2017. Increasing number of patients suffering from heart diseases and increasing healthcare expenditure have driven the growth of the market. Europe accounts for the second largest market due to continuously increasing patient population, well-developed healthcare sector, high healthcare expenditure, and government support for the research and development. Asia Pacific is the fastest growing market.

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/972 .

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.